Mauna Kea Technologies announced the appointment of Côme de La Tour du Pin as its Chief Financial Officer and a member of the Executive Committee. Prior to joining Mauna Kea Technologies, Côme served as Chief Financial Officer of Lysogene, a development-stage, gene therapy company listed on Euronext where his responsibilities included financial management and budgeting, investor relations and capital raising. Previous experience includes investor communication roles at Ipsen and Groupe Casino, and as an auditor with PricewaterhouseCoopers (PwC).

Côme holds a master's degree from Emlyon Business School.